Creative Planning’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $656K | Buy |
37,604
+4,485
| +14% | +$78.3K | ﹤0.01% | 2222 |
|
|
2025
Q1 | $417K | Buy |
33,119
+2,913
| +10% | +$36.6K | ﹤0.01% | 2459 |
|
|
2024
Q4 | $319K | Sell |
30,206
-5,057
| -14% | -$53.4K | ﹤0.01% | 2603 |
|
|
2024
Q3 | $511K | Buy |
35,263
+2,307
| +7% | +$33.5K | ﹤0.01% | 2089 |
|
|
2024
Q2 | $280K | Buy |
32,956
+594
| +2% | +$5.06K | ﹤0.01% | 2399 |
|
|
2024
Q1 | $331K | Buy |
32,362
+1,161
| +4% | +$11.9K | ﹤0.01% | 2165 |
|
|
2023
Q4 | $171K | Buy |
31,201
+3,270
| +12% | +$17.9K | ﹤0.01% | 2470 |
|
|
2023
Q3 | $106K | Buy |
+27,931
| New | +$106K | ﹤0.01% | 2378 |
|